Organs On Chip Market Size, Share, Opportunities, And Trends By Type (Liver, Kidney, Lung, Heart, Others), By Application (Drug Discovery, Toxicity Testing, Physiological Model), By Offering (Products, Service), By End-User (Research Institutes, Pharmaceutical Companies), And By Geography - Forecasts From 2023 To 2028

The organs-on-chip market was valued at US$74.827 million in 2021 and is projected to expand at a CAGR of 26.72% over the forecast period to reach US$392.621 million by 2028. 

An organ-on-a-chip (OOC) is a functional microchip housing living cells that have the possibility of simulating the activities, mechanics, and physiological response of entire organs and organ systems, a type of artificial organ. Each organ-on-chip is about the size of a coin and contains microfluidic channels, which are lined by living human cells and interfaced with a human artificial vasculature. The organs-on-chip market has been on a steady growth pace because of the rising need for effective drug discovery and development, increasing demand for alternatives for animal models in research, increasing drug repurposing approaches, and government regulations and grants for the research. The increasing research and funding for the development of the organ-on-chip model, along with the demand for personalized medication and vast application of the chip, such as disease modelling, patient stratification, and phenotypic screening, has also led to market growth.

However, the high cost of the chip and the complexities of mimicking human organs pose a challenge for the growth of the market to continue. Therefore, the key players and researchers are doing agreements and joint ventures and increasing the fund for doing research and developing innovative and new products.

This research study examines the organs-on-chip market based on various segments: type, application, offerings, end-user, and geography. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model comprehensively analyzes the organs-on-chip industry. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the organs-on-chip market. Moreover, the research study analyzes the overall regulatory framework of the organs-on-chip sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

Organs-on-chip Market – Forecasts from 2023 to 2028 is a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the organs-on-chip market report is as below:

• Organs-on-chip market data tables and charts
• Market outlook with sections on drivers, restraints, Porter’s, and industry value chain analysis
• Market assessment by type into liver, kidney, lung, heart, and others.
• Detailed market trends, analysis, and graphical representation by application into drug discovery, toxicity testing, and physiological model and by offering into products and services.
• In-depth analysis of the organs-on-chip market by end-user into research institutes and pharmaceutical companies.
• A 360^o view of the demand for organs-on-chip solutions/services across different geographies (Americas, Europe, Middle East and Africa, and Asia Pacific) with further breakdown for key countries within those regions.

Organs On Chip Market Scope:

 

Report Metric	Details
Market Size Value in 2021	US$74.827 million
Market Size Value in 2028	US$392.621 million
Growth Rate	CAGR of 26.72% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Million
Segments Covered	Type, Application, Offering, End-User, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	AxoSim Inc., BiomimX SRL, CN Bio, Emulate Inc., InSphero AG, MIMETAS BV, Nortis Inc., TissUse GmbH.
Customization Scope	Free report customization with purchase

 

Different segments covered under the organs-on-chip market report are as below:

• By Type
  • Liver
  • Kidney
  • Lung
  • Heart
  • Others
• By Application
  • Drug Discovery
  • Toxicity Testing
  • Physiological Model
• By Offering
  • Products
  • Services
• By End-User
  • Research Institute
  • Pharmaceutical Companies
• By Geography
  • Americas
    • USA
    • Others
  • Europe, Middle East, and Africa
    • Germany
    • United Kingdom
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Others

---

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. ORGANS ON CHIP MARKET, BY TYPE

5.1. Introduction

5.2. Liver

5.3. Kidney

5.4. Lung

5.5. Heart

5.6. Others

6. ORGANS ON CHIP MARKET, BY APPLICATION

6.1. Introduction

6.2. Drug Discovery

6.3. Toxicity Testing

6.4. Physiological Model

7. ORGANS ON CHIP MARKET, BY OFFERING

7.1. Introduction

7.2. Products

7.3. Services

8. ORGANS ON CHIP MARKET, BY END-USER

8.1. Introduction

8.3. Research Institutes

8.4. Pharmaceutical Companies

9. ORGANS ON CHIP MARKET, BY GEOGRAPHY

9.1. Introduction 

9.2. Americas

9.2.1. USA

9.2.2. Others

9.3. Europe, Middle East and Africa

9.3.1. Germany

9.3.2. United Kingdom

9.3.3. Others

9.4. Asia Pacific

9.4.1. China

9.4.2. Japan

9.4.3. South Korea

9.4.4. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

10.1. Major Players and Strategy Analysis

10.2. Emerging Players and Market Lucrativeness

10.3. Mergers, Acquisitions, Agreements, and Collaborations

10.4. Vendor Competitiveness Matrix

11. COMPANY PROFILES

11.1. AxoSim Inc.

11.2. BiomimX SRL

11.3. CN Bio

11.4. Emulate Inc.

11.5. InSphero AG

11.6. MIMETAS BV

11.7. Nortis Inc.

11.8. TissUse GmbH.

AxoSim Inc.

BiomimX SRL

CN Bio

Emulate Inc.

InSphero AG

MIMETAS BV

Nortis Inc.

TissUse GmbH.